Actively Recruiting
Study of a 6-Day Low-Dose Medrol Dosepak to Reduce Opioid Use and Pain After Foot and Ankle Surgery
Led by Emory University · Updated on 2026-03-09
180
Participants Needed
2
Research Sites
26 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of a 6-day low-dose oral methylprednisolone course, known as Medrol Dosepak, on pain, nausea, and opioid use in patients undergoing foot and ankle surgeries. The study also aims to monitor any complications and patient-reported outcomes following surgery. This research addresses the opioid epidemic by exploring ways to reduce opioid exposure through multimodal pain management, focusing on forefoot, ankle, and Achilles surgeries.
CONDITIONS
Brief Title
Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients
Research Team
J
Jason Bariteau, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
